These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
578 related articles for article (PubMed ID: 22314110)
1. Combination treatment with atorvastatin plus niacin provides effective control of complex dyslipidemias: a literature review. McKenney JM Postgrad Med; 2012 Jan; 124(1):7-20. PubMed ID: 22314110 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of combination of extended release niacin and atorvastatin in patients with low levels of high density lipoprotein cholesterol. Harikrishnan S; Rajeev E; Tharakan JA; Titus T; Ajit Kumar VK; Sivasankaran S; Krishnamoorthy KM; Nair K Indian Heart J; 2008; 60(3):215-22. PubMed ID: 19240310 [TBL] [Abstract][Full Text] [Related]
3. Hypertriglyceridemia: a review of clinical relevance and treatment options: focus on cerivastatin. Breuer HW Curr Med Res Opin; 2001; 17(1):60-73. PubMed ID: 11464448 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and tolerability of atorvastatin/fenofibrate fixed-dose combination tablet compared with atorvastatin and fenofibrate monotherapies in patients with dyslipidemia: a 12-week, multicenter, double-blind, randomized, parallel-group study. Davidson MH; Rooney MW; Drucker J; Eugene Griffin H; Oosman S; Beckert M; Clin Ther; 2009 Dec; 31(12):2824-38. PubMed ID: 20110022 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic equivalence of the generic and the reference atorvastatin in patients with increased coronary risk. Boh M; Opolski G; Poredos P; Ceska R; Jezovnik M Int Angiol; 2011 Aug; 30(4):366-74. PubMed ID: 21747355 [TBL] [Abstract][Full Text] [Related]
6. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study. Strandberg TE; Feely J; Sigurdsson EL; Clin Ther; 2004 Nov; 26(11):1821-33. PubMed ID: 15639694 [TBL] [Abstract][Full Text] [Related]
7. 'Trig-onometry': non-high-density lipoprotein cholesterol as a therapeutic target in dyslipidaemia. Jacobson TA Int J Clin Pract; 2011 Jan; 65(1):82-101. PubMed ID: 21105969 [TBL] [Abstract][Full Text] [Related]
8. Lipid modifying action of atorvastatin in comparison to combination of atorvastatin and nicotinic acid in patients with ischaemic heart disease. Santanu G; Suhrita P; Mookerjee S; Tania K; Mita S; Pramit G; Sharmila G; Miraj M; Debdutta M Indian Heart J; 2011; 63(5):434-7. PubMed ID: 23550422 [TBL] [Abstract][Full Text] [Related]
9. Advances in drug treatment of dyslipidemia: focus on atorvastatin. Davignon J Can J Cardiol; 1998 May; 14 Suppl B():28B-38B. PubMed ID: 9627539 [TBL] [Abstract][Full Text] [Related]
10. A new paradigm for managing dyslipidemia with combination therapy: laropiprant + niacin + simvastatin. Yiu KH; Cheung BM; Tse HF Expert Opin Investig Drugs; 2010 Mar; 19(3):437-49. PubMed ID: 20141348 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of atorvastatin after LDL-cholesterol-based dose selection in high risk dyslipidaemic patients: results of the target dose study. Ducobu J; Claeys M; Commers K; Van Mieghem W; Nachtergaele H; Vandenbroucke M; Deforce J Curr Med Res Opin; 2007 Aug; 23(8):1821-7. PubMed ID: 17609019 [TBL] [Abstract][Full Text] [Related]
13. Niacin as a component of combination therapy for dyslipidemia. Miller M Mayo Clin Proc; 2003 Jun; 78(6):735-42. PubMed ID: 12934785 [TBL] [Abstract][Full Text] [Related]
15. Assessment of the efficacy and tolerability of a fixed dose combination of atorvastatin 10 mg + metformin SR 500 mg in diabetic dyslipidaemia in adult Indian patients. Balasubramanian R; Varadharajan S; Kathale A; Nagraj LM; Periyandavar I; Nayak UP; Sharma A; Bolmall C; Baliga VP J Indian Med Assoc; 2008 Jul; 106(7):464-7. PubMed ID: 18975505 [TBL] [Abstract][Full Text] [Related]
17. Combined use of extended-release niacin and atorvastatin: safety and effects on lipid modification. Sang ZC; Wang F; Zhou Q; Li YH; Li YG; Wang HP; Chen SY Chin Med J (Engl); 2009 Jul; 122(14):1615-20. PubMed ID: 19719960 [TBL] [Abstract][Full Text] [Related]